Recent Insights into the Management of Pleural Infection

References

• Davies HE, Davies RJO, Davies CWH, on behalf of the BTS Pleural Disease Guideline Group. Management of pleural infection in adults: british Thoracic Society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii41–ii53. doi:10.1136/thx.2010.137000
   PubMed Web of Science ®Google Scholar
• Peters RM. Empyema thoracis: historical perspective. Ann Thorac Surg. 1989;48(2):306–308. doi:10.1016/0003-4975(89)90100-8
   PubMed Web of Science ®Google Scholar
• Meyer JA. Gotthard Bülau and closed water-seal drainage for empyema, 1875–1891. Ann Thorac Surg. 1989;48(4):597–599. doi:10.1016/s0003-4975(10)66876-2
   PubMed Web of Science ®Google Scholar
• Bender JM, Ampofo K, Sheng X, Pavia AT, Cannon-Albright L, Byington CL. Parapneumonic Empyema Deaths during Past Century, Utah. Emerg Infect Dis. 2009;15(1):44–48. doi:10.3201/eid1501.080618
   PubMed Web of Science ®Google Scholar
• Meyer CN, Armbruster K, Kemp M, et al. Pleural infection: a retrospective study of clinical outcome and the correlation to known etiology, co-morbidity and treatment factors. BMC Pulm Med. 2018;18(1):160. doi:10.1186/s12890-018-0726-1
   PubMed Web of Science ®Google Scholar
• Gupta I, Eid SM, Gillaspie EA, Broderick S, Shafiq M. Epidemiologic Trends in Pleural Infection. A Nationwide Analysis. Annals ATS. 2021;18(3):452–459. doi:10.1513/AnnalsATS.202001-075OC
   Web of Science ®Google Scholar
• Bedawi EO, Hassan M, McCracken D, Rahman NM. Pleural infection: a closer look at the etiopathogenesis, microbiology and role of antibiotics. Expert Rev Respir Med. 2019;13(4):337–347. doi:10.1080/17476348.2019.1578212
   PubMed Web of Science ®Google Scholar
• Brims F, Popowicz N, Rosenstengel A, et al. Bacteriology and clinical outcomes of patients with culture-positive pleural infection in Western Australia: a 6-year analysis: empyema in Western Australia 2006–2011. Respirology. 2019;24(2):171–178. doi:10.1111/resp.13395
   PubMed Web of Science ®Google Scholar
• Rahman NM, Kahan BC, Miller RF, Gleeson FV, Nunn AJ, Maskell NA. A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. Chest. 2014;145(4):848–855. doi:10.1378/chest.13-1558
   PubMed Web of Science ®Google Scholar
• Corcoran JP, Psallidas I, Gerry S, et al. Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study. Eur Respir J. 2020;56(5):2000130. doi:10.1183/13993003.00130-2020
   PubMed Web of Science ®Google Scholar
• Nayak R, Brogly SB, Lajkosz K, Lougheed MD, Petsikas D. Two decades of thoracic empyema in Ontario, Canada. Chest. 2020;157(5):1114–1116. doi:10.1016/j.chest.2019.11.040
   PubMed Web of Science ®Google Scholar
• Grijalva CG, Zhu Y, Nuorti JP, Griffin MR. Emergence of parapneumonic empyema in the USA. Thorax. 2011;66(8):663–668. doi:10.1136/thx.2010.156406
   PubMed Web of Science ®Google Scholar
• Bobbio A, Bouam S, Frenkiel J, et al. Epidemiology and prognostic factors of pleural empyema. Thorax. 2021:thoraxjnl-2020-215267. doi:10.1136/thoraxjnl-2020-215267.
   PubMed Web of Science ®Google Scholar
• Lehtomäki A, Nevalainen R, Ukkonen M, Nieminen J, Laurikka J, Khan J. Trends in the incidence, etiology, treatment, and outcomes of pleural infections in adults over a decade in a Finnish University Hospital. Scand J Surg. 2020;109(2):127–132. doi:10.1177/1457496919832146
   PubMed Web of Science ®Google Scholar
• Shen H-N, Lu C-L, Li C-Y. Epidemiology of pleural infections in Taiwan from 1997 through 2008: pleural infections in Taiwan. Respirology. 2012;17(7):1086–1093. doi:10.1111/j.1440-1843.2012.02214.x
   PubMed Web of Science ®Google Scholar
• Mitchell MA, Deschner E, Dhaliwal I, Amjadi K, Chee A. Association of patient demographics and comorbidities with clinical outcomes in adults hospitalized for Empyema. Ann Am Thorac Soc. 2021;18(5):904–906. doi:10.1513/AnnalsATS.202008-1011RL
   PubMed Web of Science ®Google Scholar
• Cargill TN, Hassan M, Corcoran JP, et al. A systematic review of comorbidities and outcomes of adult patients with pleural infection. Eur Respir J. 2019. doi:10.1183/13993003.00541-2019
   Web of Science ®Google Scholar
• Wong D, Yap E. Pleural infection in a New Zealand centre: high incidence in Pacific people and RAPID score as a prognostic tool: pleural infection in New Zealand. Intern Med J. 2016;46(6):703–709. doi:10.1111/imj.13087
   PubMed Web of Science ®Google Scholar
• Ahmed RA, Marrie TJ, Huang JQ. Thoracic empyema in patients with community-acquired pneumonia. Am J Med. 2006;119(10):877–883. doi:10.1016/j.amjmed.2006.03.042
   PubMed Web of Science ®Google Scholar
• Lehtomäki AI, Nevalainen RM, Toikkanen VJ, et al. Pleural infection—an indicator of morbidity and increased burden on health care. Interact Cardiovasc Thorac Surg. 2020;31(4):513–518. doi:10.1093/icvts/ivaa147
   PubMed Web of Science ®Google Scholar
• Schweigert M, Solymosi N, Dubecz A, et al. Surgery for parapneumonic pleural empyema--What influence does the rising prevalence of multimorbidity and advanced age has on the current outcome? Surgeon. 2016;14(2):69–75. doi:10.1016/j.surge.2014.05.002
   PubMed Web of Science ®Google Scholar
• Cohen E, Mahant S, Dell SD, et al. The long-term outcomes of pediatric pleural empyema: a prospective study. Arch Pediatr Adolesc Med. 2012;166(11):999–1004. doi:10.1001/archpediatrics.2012.1055
   PubMedGoogle Scholar
• Chalmers JD, Singanayagam A, Murray MP, Scally C, Fawzi A, Hill AT. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax. 2009;64(7):592–597. doi:10.1136/thx.2008.105080
   PubMed Web of Science ®Google Scholar
• Amaro R, Sellarés J, Riesco J, Cillloniz C, Abad E, Torres A. Late-breaking abstract: smoking is associated with higher incidence of parapneumonic effusion in community-acquired pneumonia. Eur Respir J. 2014;44(Suppl 58):P318.
   Google Scholar
• Noppen M. Normal volume and cellular contents of pleural fluid. Curr Opin Pulm Med. 2001;7(4):180–182. doi:10.1097/00063198-200107000-00002
   PubMedGoogle Scholar
• Psallidas I, Kanellakis NI, Bhatnagar R, et al. A pilot feasibility study in establishing the role of ultrasound-guided pleural biopsies in pleural infection (The AUDIO Study). Chest. 2018;154(4):766–772. doi:10.1016/j.chest.2018.02.031
   PubMed Web of Science ®Google Scholar
• Hassan M, Cargill T, Harriss E, et al. The microbiology of pleural infection in adults: a systematic review. Eur Respir J. 2019;54(3):1900542. doi:10.1183/13993003.00542-2019
   PubMed Web of Science ®Google Scholar
• Maskell NA, Batt S, Hedley EL, Davies CWH, Gillespie SH, Davies RJO. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med. 2006;174(7):817–823. doi:10.1164/rccm.200601-074OC
   PubMed Web of Science ®Google Scholar
• Wrightson JM, Wray JA, Street TL, et al. Absence of atypical pathogens in pleural infection. Chest. 2015;148(3):e102–e103. doi:10.1378/chest.15-1130
   PubMed Web of Science ®Google Scholar
• Lisboa T, Waterer GW, Lee YCG. Pleural infection: changing bacteriology and its implications: pleural infection: changing bacteriology. Respirology. 2011;16(4):598–603. doi:10.1111/j.1440-1843.2011.01964.x
   PubMed Web of Science ®Google Scholar
• Chen KY, Hsueh PR, Liaw YS, Yang PC, Luh KT. A 10-year experience with bacteriology of acute thoracic empyema: emphasis on Klebsiella pneumoniae in patients with diabetes mellitus. Chest. 2000;117(6):1685–1689.
   PubMed Web of Science ®Google Scholar
• Lin Y-C, Tu C-Y, Chen W, et al. An urgent problem of aerobic gram-negative pathogen infection in complicated parapneumonic effusions or empyemas. Internal Med. 2007;46(15):1173–1178. doi:10.2169/internalmedicine.46.6451
   PubMed Web of Science ®Google Scholar
• Tu C-Y, Hsu W-H, Hsia T-C, et al. The changing pathogens of complicated parapneumonic effusions or empyemas in a medical intensive care unit. Intensive Care Med. 2006;32(4):570–576. doi:10.1007/s00134-005-0064-7
   PubMed Web of Science ®Google Scholar
• Richet H. Seasonality in Gram-negative and healthcare-associated infections. Clin Microbiol Infect. 2012;18(10):934–940. doi:10.1111/j.1469-0691.2012.03954.x
   PubMed Web of Science ®Google Scholar
• Hassan M, Corcoran JP, Daneshvar C. Factors associated with variations in the rate of referrals and microbiology of pleural infection. Expert Rev Respir Med. 2020;14(11):1165–1171. doi:10.1080/17476348.2020.1804874
   PubMed Web of Science ®Google Scholar
• Corcoran JP, Wrightson JM, Belcher E, DeCamp MM, Feller-Kopman D, Rahman NM. Pleural infection: past, present, and future directions. Lancet Respir Med. 2015;3(7):563–577. doi:10.1016/S2213-2600(15)00185-X
   PubMed Web of Science ®Google Scholar
• Boyanova L, Djambazov V, Gergova G, et al. Anaerobic microbiology in 198 cases of pleural empyema: a Bulgarian study. Anaerobe. 2004;10(5):261–267. doi:10.1016/j.anaerobe.2004.06.001
   PubMed Web of Science ®Google Scholar
• Dyrhovden R, Nygaard RM, Patel R, Ulvestad E, Kommedal Ø. The bacterial aetiology of pleural empyema. A descriptive and comparative metagenomic study. Clin Microbiol Infect. 2019;25(8):981–986. doi:10.1016/j.cmi.2018.11.030
   PubMed Web of Science ®Google Scholar
• Ko SC, Chen KY, Hsueh PR, Luh KT, Yang PC. Fungal empyema thoracis: an emerging clinical entity. Chest. 2000;117(6):1672–1678.
   PubMed Web of Science ®Google Scholar
• Bedawi EO, Hassan M, Rahman NM. Recent developments in the management of pleural infection: a comprehensive review. Clin Respir J. 2018;12(8):2309–2320. doi:10.1111/crj.12941
   PubMed Web of Science ®Google Scholar
• Brixey AG, Luo Y, Skouras V, Awdankiewicz A, Light RW. The efficacy of chest radiographs in detecting parapneumonic effusions: the efficacy of chest radiographs. Respirology. 2011;16(6):1000–1004. doi:10.1111/j.1440-1843.2011.02006.x
   PubMed Web of Science ®Google Scholar
• Tsujimoto N, Saraya T, Light RW, et al. A simple method for differentiating complicated parapneumonic effusion/empyema from parapneumonic effusion using the split pleura sign and the amount of pleural effusion on thoracic CT. PLoS One. 2015;10(6):e0130141. doi:10.1371/journal.pone.0130141
   PubMed Web of Science ®Google Scholar
• Porcel JM, Pardina M, Alemán C, Pallisa E, Light RW, Bielsa S. Computed tomography scoring system for discriminating between parapneumonic effusions eventually drained and those cured only with antibiotics: CT for parapneumonic effusions. Respirology. 2017;22(6):1199–1204. doi:10.1111/resp.13040
   PubMed Web of Science ®Google Scholar
• Kearney SE, Davies CW, Davies RJ, Gleeson FV. Computed tomography and ultrasound in parapneumonic effusions and empyema. Clin Radiol. 2000;55(7):542–547. doi:10.1053/crad.1999.0480
   PubMed Web of Science ®Google Scholar
• Reissig A, Copetti R, Mathis G, et al. Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia: a prospective, multicenter, diagnostic accuracy study. Chest. 2012;142(4):965–972. doi:10.1378/chest.12-0364
   PubMed Web of Science ®Google Scholar
• Hassan M, Mercer RM, Rahman NM. Thoracic ultrasound in the modern management of pleural disease. Eur Respir Rev. 2020;29(156):190136. doi:10.1183/16000617.0136-2019
   PubMed Web of Science ®Google Scholar
• Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest. 2000;118(4):1158–1171. doi:10.1378/chest.118.4.1158
   PubMed Web of Science ®Google Scholar
• Varsamas C, Kalkanis A, Gourgoulianis KI, Malli F. The use of a novel quantitative marker of echogenicity of pleural fluid in parapneumonic pleural effusions. Can Respir J. 2020;2020:1283590. doi:10.1155/2020/1283590
   PubMed Web of Science ®Google Scholar
• Heffner JE, Brown LK, Barbieri C, DeLeo JM. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med. 1995;151(6):1700–1708. doi:10.1164/ajrccm.151.6.7767510
   PubMed Web of Science ®Google Scholar
• Maskell NA, Gleeson FV, Darby M, Davies RJO. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions. CHEST. 2004;126(6):2022–2024. doi:10.1378/chest.126.6.2022
   PubMed Web of Science ®Google Scholar
• Isenstein D, Honig E. Proteus vulgaris empyema and increased pleural fluid pH. CHEST. 1990;97(2):511. doi:10.1378/chest.97.2.511b
   PubMed Web of Science ®Google Scholar
• Fitzgerald DB, Leong SL, Budgeon CA, et al. Relationship of pleural fluid pH and glucose: a multi-centre study of 2,971 cases. J Thorac Dis. 2019;11(1):123–130. doi:10.21037/jtd.2018.12.101
   PubMed Web of Science ®Google Scholar
• Falguera M, Carratalà J, Bielsa S, et al. Predictive factors, microbiology and outcome of patients with parapneumonic effusion. Eur Respir J. 2011;38(5):1173. doi:10.1183/09031936.00000211
   PubMed Web of Science ®Google Scholar
• Porcel JM, Bielsa S, Esquerda A, Ruiz-González A, Falguera M. Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions. Eur J Intern Med. 2012;23(5):447–450. doi:10.1016/j.ejim.2012.03.002
   PubMed Web of Science ®Google Scholar
• Porcel JM, Valencia H, Bielsa S. Factors influencing pleural drainage in parapneumonic effusions. Revista Clínica Española. 2016;216(7):361–366. doi:10.1016/j.rce.2016.04.004
   PubMed Web of Science ®Google Scholar
• Menzies SM, Rahman NM, Wrightson JM, et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax. 2011;66(8):658. doi:10.1136/thx.2010.157842
   PubMed Web of Science ®Google Scholar
• Dixon G, Lama-Lopez A, Bintcliffe OJ, Morley AJ, Hooper CE, Maskell NA. The role of serum procalcitonin in establishing the diagnosis and prognosis of pleural infection. Respir Res. 2017;18(1):30. doi:10.1186/s12931-017-0501-5
   PubMed Web of Science ®Google Scholar
• McCann FJ, Chapman SJ, Yu WC, Maskell NA, Davies RJO, Lee YCG. Ability of procalcitonin to discriminate infection from non-infective inflammation using two pleural disease settings. PLoS One. 2012;7(12):e49894. doi:10.1371/journal.pone.0049894
   PubMed Web of Science ®Google Scholar
• Insa R, Marín M, Martín A, et al. Systematic use of universal 16S rRNA Gene Polymerase Chain Reaction (PCR) and sequencing for processing pleural effusions improves conventional culture techniques. Medicine. 2012;91(2):103–110. doi:10.1097/MD.0b013e31824dfdb0
   PubMed Web of Science ®Google Scholar
• Gadsby NJ, Russell CD, McHugh MP, et al. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis. 2016;62(7):817–823. doi:10.1093/cid/civ1214
   PubMed Web of Science ®Google Scholar
• Zhou F, Sun S, Sun X, Chen Y, Yang X. Rapid and sensitive identification of pleural and peritoneal infections by droplet digital PCR. Folia Microbiol. 2021;66(2):213–219. doi:10.1007/s12223-020-00834-0
   PubMed Web of Science ®Google Scholar
• Franchetti L, Schumann DM, Tamm M, Jahn K, Stolz D. Multiplex bacterial polymerase chain reaction in a cohort of patients with pleural effusion. BMC Infect Dis. 2020;20(1):99. doi:10.1186/s12879-020-4793-6
   PubMed Web of Science ®Google Scholar
• Teixeira LR, Sasse SA, Villarino MA, Nguyen T, Mulligan ME, Light RW. Antibiotic levels in empyemic pleural fluid. Chest. 2000;117(6):1734–1739. doi:10.1378/chest.117.6.1734
   PubMed Web of Science ®Google Scholar
• Bhatnagar R, Skouras VS, Rahman NM, Psallidas I. Antibiotics for pleural infections. In: Aliberti S, Chalmers JD, Pletz MW editors. Anti-Infectives and the Lung. European Respiratory Society; 2017:253–263. doi:10.1183/2312508X.10005816.
   Google Scholar
• Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017;153(6):e129–e146. doi:10.1016/j.jtcvs.2017.01.030
   PubMed Web of Science ®Google Scholar
• Porcel JM, Ferreiro L, Rumi L, et al. Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial. Pleura Peritoneum. 2020;5(1). doi:10.1515/pp-2019-0027
   PubMed Web of Science ®Google Scholar
• Ng T, Ryder BA, Maziak DE, Shamji FM. Treatment of postpneumonectomy empyema with debridement followed by continuous antibiotic irrigation. J Am Coll Surg. 2008;206(6):1178–1183. doi:10.1016/j.jamcollsurg.2008.01.005
   PubMed Web of Science ®Google Scholar
• Rana MA, Rahman BAE, Mady AF, et al. Intra-pleural colistin methanesulfonate therapy for pleural infection caused by carbapenem-resistant acinetobacter baumannii: a successful case report. Infect Dis Rep. 2014;6:3. doi:10.4081/idr.2014.5413
   Google Scholar
• Chao Y-K, Lee C-H, Liu K-S, Wang Y-C, Wang C-W, Liu S-J. Sustained release of bactericidal concentrations of penicillin in the pleural space via an antibiotic-eluting pigtail catheter coated with electrospun nanofibers: results from in vivo and in vitro studies. Int J Nanomedicine. 2015;10:3329–3336. doi:10.2147/IJN.S82228
   PubMed Web of Science ®Google Scholar
• Rahman NM, Maskell NA, Davies CWH, et al. The relationship between chest tube size and clinical outcome in pleural infection. CHEST. 2010;137(3):536–543. doi:10.1378/chest.09-1044
   PubMed Web of Science ®Google Scholar
• Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365(6):518–526. doi:10.1056/NEJMoa1012740
   PubMed Web of Science ®Google Scholar
• Karandashova S, Florova G, Azghani AO, et al. Intrapleural adenoviral delivery of human plasminogen activator inhibitor–1 exacerbates tetracycline-induced pleural injury in rabbits. Am J Respir Cell Mol Biol. 2013;48(1):44–52. doi:10.1165/rcmb.2012-0183OC
   PubMed Web of Science ®Google Scholar
• Idell S, Florova G, Shetty S, et al. Precision-guided, personalized intrapleural fibrinolytic therapy for empyema and complicated parapneumonic pleural effusions: the case for the fibrinolytic potential. Clin Pulm Med. 2017;24(4):163–169. doi:10.1097/CPM.0000000000000216
   PubMedGoogle Scholar
• Zhu Z, Hawthorne ML, Guo Y, et al. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. CHEST. 2006;129(6):1577–1583. doi:10.1378/chest.129.6.1577
   PubMed Web of Science ®Google Scholar
• Piccolo F, Pitman N, Bhatnagar R, et al. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. an effective and safe alternative to surgery. Annals ATS. 2014;11(9):1419–1425. doi:10.1513/AnnalsATS.201407-329OC
   Google Scholar
• Porcel JM. Dual intracavitary therapy for pleural infections: leaving reluctance behind. Eur Respir J. 2019;54(2):1901001. doi:10.1183/13993003.01001-2019
   PubMed Web of Science ®Google Scholar
• Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med. 2004;170(1):49–53. doi:10.1164/rccm.200312-1740OC
   PubMed Web of Science ®Google Scholar
• Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax. 1997;52(5):416–421. doi:10.1136/thx.52.5.416
   PubMed Web of Science ®Google Scholar
• Maskell NA, Davies CWH, Nunn AJ, et al. U.K. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005;352(9):865–874. doi:10.1056/NEJMoa042473
   PubMed Web of Science ®Google Scholar
• Gervais DA, Levis DA, Hahn PF, Uppot RN, Arellano RS, Mueller PR. Adjunctive intrapleural tissue plasminogen activator administered via chest tubes placed with imaging guidance: effectiveness and risk for hemorrhage. Radiology. 2008;246(3):956–963. doi:10.1148/radiol.2463070235
   PubMed Web of Science ®Google Scholar
• Kheir F, Cheng G, Rivera E, et al. Concurrent versus sequential intrapleural instillation of tissue plasminogen activator and deoxyribonuclease for pleural infection. J Bronchology Interv Pulmonol. 2018;25(2):125–131. doi:10.1097/LBR.0000000000000461
   PubMed Web of Science ®Google Scholar
• Majid A, Kheir F, Folch A, et al. Concurrent intrapleural instillation of tissue plasminogen activator and dnase for pleural infection. A Single-center experience. Ann Am Thorac Soc. 2016;13(9):1512–1518. doi:10.1513/AnnalsATS.201602-127OC
   PubMed Web of Science ®Google Scholar
• Popowicz N, Bintcliffe O, De Fonseka D, et al. Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The Alteplase dose assessment for pleural infection therapy project. Ann Am Thorac Soc. 2017;14(6):929–936. doi:10.1513/AnnalsATS.201609-673OC
   PubMed Web of Science ®Google Scholar
• Chambers A, Routledge T, Dunning J, Scarci M. Is video-assisted thoracoscopic surgical decortication superior to open surgery in the management of adults with primary empyema? Interact Cardiovasc Thorac Surg. 2010;11:171–177. doi:10.1510/icvts.2010.240408
   PubMed Web of Science ®Google Scholar
• Yeung C, Dawson J, Gilbert S. Uniportal video-assisted thoracoscopy approach to the management of non-pulmonary diseases of the chest. J Thorac Dis. 2019;11(S16):S2062–S2068. doi:10.21037/jtd.2019.03.21
   PubMed Web of Science ®Google Scholar
• Migliore M. Nonintubated uniportal video-assisted thoracic surgery for chest infections. Thorac Surg Clin. 2020;30(1):33–39. doi:10.1016/j.thorsurg.2019.08.004
   PubMed Web of Science ®Google Scholar
• Suchar AM, Zureikat AH, Glynn L, Statter MB, Lee J, Liu DC. Ready for the frontline: is early thoracoscopic decortication the new standard of care for advanced pneumonia with empyema? Am Surg. 2006;72(8):688–693. doi:10.1177/000313480607200806
   PubMed Web of Science ®Google Scholar
• Marks DJB, Fisk MD, Koo CY, et al. Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral centre. PLoS One. 2012;7(1):e30074–e30074. doi:10.1371/journal.pone.0030074
   PubMed Web of Science ®Google Scholar
• Bilgin M, Akcali Y, Oguzkaya F. Benefits of early aggressive management of empyema thoracis. ANZ J Surg. 2006;76(3):120–122. doi:10.1111/j.1445-2197.2006.03666.x
   PubMed Web of Science ®Google Scholar
• Mondoni M, Saderi L, Trogu F, et al. Medical thoracoscopy treatment for pleural infections: a systematic review and meta-analysis. BMC Pulm Med. 2021;21(1):127. doi:10.1186/s12890-021-01492-9
   PubMed Web of Science ®Google Scholar
• Kheir F, Thakore S, Mehta H, et al. Intrapleural fibrinolytic therapy versus early medical thoracoscopy for treatment of pleural infection. randomized controlled clinical trial. Ann Am Thorac Soc. 2020;17(8):958–964. doi:10.1513/AnnalsATS.202001-076OC
   PubMed Web of Science ®Google Scholar
• Brutsche MH, Tassi G-F, Györik S, et al. Treatment of sonographically stratified multiloculated thoracic empyema by medical thoracoscopy. Chest. 2005;128(5):3303–3309. doi:10.1378/chest.128.5.3303
   PubMed Web of Science ®Google Scholar
• Tassi GF, Marchetti GP, Pinelli V, Chiari S. Practical management of pleural empyema. Monaldi Arch Chest Dis. 2010;73(3):124–129. doi:10.4081/monaldi.2010.296
   PubMedGoogle Scholar
• Sumalani KK, Rizvi NA, Asghar A. Role of medical thoracoscopy in the management of multiloculated empyema. BMC Pulm Med. 2018;18(1):179. doi:10.1186/s12890-018-0745-y
   PubMed Web of Science ®Google Scholar
• Hooper CE, Edey AJ, Wallis A, et al. Pleural irrigation trial (PIT): a randomised controlled trial of pleural irrigation with normal saline versus standard care in patients with pleural infection. Eur Respir J. 2015;46(2):456. doi:10.1183/09031936.00147214
   PubMed Web of Science ®Google Scholar
• Porcel JM, Valencia H, Bielsa S. Manual intrapleural saline flushing plus urokinase: a potentially useful therapy for complicated parapneumonic effusions and empyemas. Lung. 2017;195(1):135–138. doi:10.1007/s00408-016-9964-2
   PubMed Web of Science ®Google Scholar
• Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc. 2006;3(1):75–80. doi:10.1513/pats.200510-113JH
   PubMedGoogle Scholar
• Togo S, Ouattara MA, Sangaré I, et al. Management for pediatric pleural empyema in resource-poor country: is chest tube drainage with antiseptic lavage-irrigation better than tube thoracostomy alone? SS. 2015;06(12):541–548. doi:10.4236/ss.2015.612077
   Google Scholar
• Jouneau S, Letheulle J, Desrues B. Repeated therapeutic thoracentesis to manage complicated parapneumonic effusions. Curr Opin Pulm Med. 2015;21(4):387–392. doi:10.1097/MCP.0000000000000171
   PubMed Web of Science ®Google Scholar
• Letheulle J, Tattevin P, Saunders L, et al. Iterative thoracentesis as first-line treatment of complicated parapneumonic effusion. PLoS One. 2014;9(1):e84788. doi:10.1371/journal.pone.0084788
   PubMed Web of Science ®Google Scholar
• Nielsen J, Meyer CN, Rosenlund S. Outcome and clinical characteristics in pleural empyema: a retrospective study. Scand J Infect Dis. 2011;43(6–7):430–435. doi:10.3109/00365548.2011.562527
   PubMed Web of Science ®Google Scholar
• Marks DJB, Fisk MD, Koo CY, et al. Thoracic Empyema: a 12-year study from a uk tertiary cardiothoracic referral centre. Wilkinson RJ, ed. PLoS One. 2012;7(1):e30074. doi:10.1371/journal.pone.0030074
   PubMed Web of Science ®Google Scholar
• Heffner JE, McDonald J, Barbieri C, Klein J. Management of parapneumonic effusions. An analysis of physician practice patterns. Arch Surg. 1995;130(4):433–438. doi:10.1001/archsurg.1995.01430040095021
   PubMedGoogle Scholar
• Lindstrom ST, Kolbe J. Community acquired parapneumonic thoracic empyema: predictors of outcome. Respirology. 1999;4(2):173–179.
   PubMedGoogle Scholar
• Park C-K, Oh H-J, Choi H-Y, et al. Microbiological characteristics and predictive factors for mortality in pleural infection: a single-center cohort study in Korea. Trottein F, ed. PLoS One. 2016;11(8):e0161280. doi:10.1371/journal.pone.0161280
   PubMed Web of Science ®Google Scholar
• Søgaard M, Nielsen RB, Nørgaard M, Kornum JB, Schønheyder HC, Thomsen RW. Incidence, length of stay, and prognosis of hospitalized patients with pleural empyema. Chest. 2014;145(1):189–192. doi:10.1378/chest.13-1912
   PubMed Web of Science ®Google Scholar
• Ferguson AD, Prescott RJ, Selkon JB, Watson D, Swinburn CR. The clinical course and management of thoracic empyema. QJM. 1996;89(4):285–289. doi:10.1093/qjmed/89.4.285
   PubMed Web of Science ®Google Scholar
• Davies CW, Kearney SE, Gleeson FV, Davies RJ. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1682–1687. doi:10.1164/ajrccm.160.5.9903002
   PubMed Web of Science ®Google Scholar
• White HD, White BAA, Song J, Fader R, Quiroga P, Arroliga AC. Pleural infections: a 9-year review of bacteriology, case characteristics and mortality. Am J Med Sci. 2013;345(5):349–354. doi:10.1097/MAJ.0b013e318259bd24
   PubMed Web of Science ®Google Scholar
• Chen C-H, Chen W, Chen H-J, et al. Transthoracic ultrasonography in predicting the outcome of small-bore catheter drainage in empyemas or complicated parapneumonic effusions. Ultrasound Med Biol. 2009;35(9):1468–1474. doi:10.1016/j.ultrasmedbio.2009.04.021
   PubMed Web of Science ®Google Scholar
• Wu J, Liu C, Lee S, Kuo Y, Hsieh T. Assessment of the charlson comorbidity index score, CHADS2 and CHA2DS2-VASc scores in predicting death in patients with thoracic empyema. Heart Lung. 2018;47(2):157–161. doi:10.1016/j.hrtlng.2017.12.003
   PubMed Web of Science ®Google Scholar
• Porcel JM. PILOTing towards a RAPID predictor of mortality for infectious pleural effusions. Eur Respir J. 2020;56(5):2002425. doi:10.1183/13993003.02425-2020
   PubMed Web of Science ®Google Scholar